The opportunities and challenges surrounding patient centricity and patient-centric trials in China.
Sy Pretorius
Advertisement
Articles by Sy Pretorius
Advertisement
Latest Updated Articles
- Patient-Centric Trials in China: An Opportunity to Innovate
Published: June 18th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
5
